2-[2-[2-CHLORO-3-[(1,3-DIHYDRO-3, 3-DIMETHYL-1-PROPYL-2H- INDOL-2-YLIDENE)ETHYLIDENE]-1- CYCLOHEXEN-1-YL]ETHENYL]-3,3- DIMETHYL-1-PROPYLINDOLIUM IODIDE structure
|
Common Name | 2-[2-[2-CHLORO-3-[(1,3-DIHYDRO-3, 3-DIMETHYL-1-PROPYL-2H- INDOL-2-YLIDENE)ETHYLIDENE]-1- CYCLOHEXEN-1-YL]ETHENYL]-3,3- DIMETHYL-1-PROPYLINDOLIUM IODIDE | ||
|---|---|---|---|---|
| CAS Number | 207399-07-3 | Molecular Weight | 667.10500 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C36H44ClIN2 | Melting Point | 232-234ºC | |
| MSDS | Chinese USA | Flash Point | N/A | |
Use of 2-[2-[2-CHLORO-3-[(1,3-DIHYDRO-3, 3-DIMETHYL-1-PROPYL-2H- INDOL-2-YLIDENE)ETHYLIDENE]-1- CYCLOHEXEN-1-YL]ETHENYL]-3,3- DIMETHYL-1-PROPYLINDOLIUM IODIDEIR-780 iodide is a near‐infrared fluorescent (NIF) dye for the exclusive characterization of human CSCs through the HIF‐1α/glycolysis dependent mitochondrial transporter ABCB10's activity. |
| Name | 2-[2-[2-chloro-3-[(1,3-dihydro-3,3-dimethyl-1-propyl-2h-indol-2-ylidene)ethylidene]-1-cyclohexen-1-yl]ethenyl]-3,3-dimethyl-1-propylindolium iodide |
|---|---|
| Synonym | More Synonyms |
| Melting Point | 232-234ºC |
|---|---|
| Molecular Formula | C36H44ClIN2 |
| Molecular Weight | 667.10500 |
| Exact Mass | 666.22400 |
| PSA | 6.25000 |
| LogP | 6.75170 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Safety Phrases | S22-S24/25 |
| RIDADR | NONH for all modes of transport |
|
~95%
2-[2-[2-CHLO... CAS#:207399-07-3 |
| Literature: Kang, Nam-Young; Park, Sung-Jin; Ang, Xiao Wei Emmiline; Samanta, Animesh; Driessen, Wouter H. P.; Ntziachristos, Vasilis; Vasquez, Kristine O.; Peterson, Jeffrey D.; Yun, Seong-Wook; Chang, Young-Tae Chemical Communications, 2014 , vol. 50, # 50 p. 6589 - 6591 |
|
~%
2-[2-[2-CHLO... CAS#:207399-07-3 |
| Literature: WO2011/119114 A1, ; |
|
~%
2-[2-[2-CHLO... CAS#:207399-07-3 |
| Literature: WO2011/119114 A1, ; |
|
Direct chemotherapeutic dual drug delivery through intra-articular injection for synergistic enhancement of rheumatoid arthritis treatment.
Sci. Rep. 5 , 14713, (2015) The effectiveness of systemic rheumatoid arthritis (RA) treatments is limited by difficulties in achieving therapeutic doses within articular joints. We evaluated the ability of intra-articular admini... |
| 11-Chloro-1,1'-di-n-propyl-3,3,3',3'-tetraMethyl-10,12-triMethyleneindatricarbocyanine iodide |
| IR-780 IODIDE |
| 11-CHLORO-1,1''-DIPROPYL-3,3,3'',3''-TETRAMETHYL-10,12-TRIMETHYLENEINDATRICARBOCYANINE IODIDE |
| MFCD00191907 |
| IR780 |
| 2-[2-[2-CHLORO-3-[(1,3-DIHYDRO-3, 3-DIMETHYL-1-PROPYL-2H- INDOL-2-YLIDENE)ETHYLIDENE]-1- CYCLOHEXEN-1-YL]ETHENYL]-3,3- DIMETHYL-1-PROPYLINDOLIUM IODIDE |